This statistic shows the leading pharmaceutical and biotechnology companies in the United Kingdom (UK) in 2015, based on market value. The values are based on the 2015 Financial Times Global 500 list. In this year GlaxoSmithKline ranked highest on the list with a market value worth 75.2 billion British pounds. GlaxoSmithKline also ranks among the top biotech companies by profit.The Anglo-Swedish firm, AstraZeneca followed with a market value of around 58.5 billion British pounds.
GlaxoSmithKline is a British pharmaceutical company with its headquarters based in London, United Kingdom. The company manufactures products for major disease areas including respiratory disorders such as asthma, oncology, immuno-inflammatory disorders, cardiovascular diseases, as well as manufacturing vaccinations. One of the most successful drugs manufactured and patented by GSK was Seretide/Advair which is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2016, sales of the drug Seretide/Advair generated a revenue of 835 million British pounds in Europe.
Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) in 2015, based on market value (in million GBP)
Exclusive Premium Statistic
This statistic shows the leading pharmaceutical and biotechnology companies in the United Kingdom (UK) in 2015, based on market value. The values are based on the 2015 Financial Times Global 500 list. In this year GlaxoSmithKline ranked highest on the list with a market value worth 75.2 billion British pounds. GlaxoSmithKline also ranks among the top biotech companies by profit.The Anglo-Swedish firm, AstraZeneca followed with a market value of around 58.5 billion British pounds.
GlaxoSmithKline is a British pharmaceutical company with its headquarters based in London, United Kingdom. The company manufactures products for major disease areas including respiratory disorders such as asthma, oncology, immuno-inflammatory disorders, cardiovascular diseases, as well as manufacturing vaccinations. One of the most successful drugs manufactured and patented by GSK was Seretide/Advair which is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2016, sales of the drug Seretide/Advair generated a revenue of 835 million British pounds in Europe.
More information
Statistics on "Pharmaceutical industry in the United Kingdom (UK)"
Popular Related Keywords
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Percentage return on R&D among large cap biopharma companies 2010-2018
- Top pharmaceutical and biotech companies by profit growth in 2017/2018
- Italy: number of statements about pharmaceuticals 2019, by brand
- Top pharma and biotech companies by sales growth in 2017-2018
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2018
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2018
- U.S. venture funding of therapeutic companies by disease type 2017
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Projection of top 10 global pharmaceutical companies by revenue 2018
- Change in marketing budgets of U.S. health care companies 2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- IV and SC immunoglobulin global market share 2015 by company
- Revenue forecast for global biologics market 2016-2022
- Latin America: biopharmaceuticals revenue 2018-2023
- Marketing budgets of U.S. health care companies 2016-2017
- U.S. promotional spending allocation of top 20 pharma companies 2013
- Number of companies in bio-industry in South Korea 2016, by subsector
- Forbes selected biotech companies in China & Hong Kong 2017, based on market value
- R&D investment value in bioindustry in South Korea 2016, by sector
- Combined office administrative service activities revenue in Belgium 2010-2022
